Docencia, formación, investigación y 12. calidad - Hospital General ...

More documents

Recommendations

Info

ATENCIÓN ESPECIALIZADA. DOCENCIA SERVICIOS 320 26. Martín M, Lluch A, Seguí MA, Ruiz A, Ramos M, Adrover E, Rodríguez-Lescure A, Grosse R, Calvo L, Fernandez-Chacón C, Roset M, Antón A, Isla D, del Prado PM, Iglesias L, Zaluski J, Arcusa A, López-Vega JM, Muñoz M, Mel JR. • Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen. • Annals of Oncology 2006; 17: 1205-12. 27. Carrato A, Vázquez F, Gallego J, Molina MJ. • Avances en el tratamiento del cáncer de páncreas. • Rev en Cáncer 2006;20(suppl1):33-36 28. Rodríguez-Lescure A, Maciá S, Ballester I. • Nuevos esquemas con taxanos en el tratamiento adyuvante del cáncer de mama. • Rev Cancer 2006; 20: 98-100. 29. Rodríguez-Lescure A, Martínez Ortiz MJ, Maciá S. • El futuro de Docetaxel. Perspectivas de tratamiento en las pacientes sin afectación axilar. • Rev Cancer 2006; 21: 30. Camps C, Massuti B, Jimenez A, Maestu I, Gómez RG, Isla D, González JL, Almenar D, Blasco A, Rosell R, Carrato A, Viñolas N, Batista N, García-Girón C, Galán A, López M, Blanco R, Provencio M, Diz P, Felip E. • Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small cell lung cancer: a spanish lung cancer group trial. • Ann Oncol 2006;17(3):467-72 • IF: 4.319 31. García-Closas M, Malats N, Real FX, Welch R, Kogevinas M, Chatterjee N, Pfeiffer R, Silverman D, Dosemeci M, Tardón A, Serra C, Carrato A, García-Closas R, Castaño-Vinyals G, Chanock S, Yeager M, Rothman N. • Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. • Cancer Epidemiol Biomarkers Prev 2006;15(3):536-42 • IF:4.460 32. Carrato A. • Challenges in gastrointestinal cancer. • Advances in Gastrointestinal Cancers 2006;4(3):1-2. 33. Maciá Escalante S, Rodríguez Lescure A, Martínez Banaclocha N, Gallego Plazas J, Carrato Mena A. • Patient with haemolytic anemia and treatment with capecitabine. Review of one case and literature • An Med Interna (Madrid) 2006;23(3):147-8. 34. Sastre J, Aranda E, Abad A, Gallego J, Manzano JL, Gómez A, Carrato A, López E, Díaz-Rubio E. UFT in combination with oxaliplatin: A clinical phase I study in patients with advanced or metastatic tumors. • Anticancer Drugs 2006;17(4):417-21. • IF: 1.907 35. Villanueva CM, Cantor KP, Grimalt JO, Castano-Vinyals G, Malats N, Silverman D, Tardon A, Garcia-Closas R, Serra C, Carrato A, Rothman N, Real FX, Dosemeci M, Kogevinas M. • Assessment of lifetime exposure to trihalometanes through different routes. • Occup Environ Med 2006;63(4):273-7. • IF: 1.934 36. Soto JL, Barberá VM, Saceda M, Carrato A. • Molecular biology of exocrine pancreatic cancer. • Clin Transl Oncol 2006;8(5):306-12. 37. Maciá Escalante S, Pons Sanz V, Rodríguez Lescure A, Ballester Navarro I, Carrato Mena A. • Primary hormone treatment in postmenopausal women with breast cancer. • Clin Transl Oncol 2006;8(5):372-4. Hospital General de Elche
38. Molina-Garrido MJ, Guillén Ponce C, Carrato A. • Cutaneous metastases of lung cancer. • Clin Transl Oncol 2006;8(5):330-3. 39. Maciá Escalante S, Guillén Ponce C, Rodríguez Lescure A, Ull Laita M, Carrato Mena A. ATENCIÓN ESPECIALIZADA. DOCENCIA SERVICIOS • Male patient with Hodgkin’s disease with exantema of the gallbladder of symmetric distribution in hands after chemotherapy treatment. • Ann Med Interna 2006;23(5):252-3. 40. Maciá Escalante S, Martínez Ortiz MJ, Guillén Ponce C, Rodríguez Lescure A, Carrato Mena A. • Intramedullary metastases due to non microcytic lung carcinoma. • Clin Transl Oncol 2006;8(6):459-460. 41. Samanic C, Kogevinas M, Dosemeci M, Malats N, Real FX, Garcia-Closas M, Serra C, Carrato A, García-Closas R, Sala M, Lloreta J, Tardón A, Rothman N, Silverman D. • Smoking and Bladder Cancer in Spain: Effects of Tobacco Type, Timing, Environmental Tobacco Smoke and Gender. • Cancer Epidemiol Biomarkers Prev 2006;15(7):1348-54. • IF: 4.460 42. Molina-Garrido MJ, Guillén Ponce C, Macia Escalante S, Martinez y Sevila C, Carrato Mena A. • Dysphagia and dysphonia in a woman with a previous breast cancer. • Clin Transl Oncol 2006;8(7):533-5. 43. Maciá Escalante S, Rodríguez Lescure A, García Sepulcre MF, Guillén Ponce C, Carrato Mena A. • Patient with reactivation of hepatitis B after chemotherapy. Role of lamivudine therapy. • Gastroenterol Hepatol 2006;29(7):433. 44. Molina Garrido MJ, Guillen Ponce C, Macia Escalante S, Pons Sanz V, Carrato Mena A. • Cushing’s paraneoplastic syndrome as first manifestation of an adenocarcinoma of unknown origin. • Clin Transl Oncol 2006;8(8):621-3. 45. Molina Garrido MJ, Mora Rufete A, Guillén Ponce C, Maciá Escalante S, Carrato Mena A. • Skin metastases as first manifestation of lung cancer. • Clin Transl Oncol 2006;8(8):616-7. 46. Molina-Garrido MJ, Mora Rufete A, Guillén Ponce C, Martínez y Sevila C, Carrato A. • Fever of unknown origin as first manifestation of two cases of cervix carcinoma. • An Med Interna 2006;23(8):387-8. 47. Fortuny J, Kogevinas M, Garcia-Closas M, Real FX, Tardón A, Garcia-Closas R, Serra C, Carrato A, Lloreta J, Rothman N, Villanueva C, Dosemeci M, Malats N, Silverman D. • Use of analgesics and nonsteroidal anti-inflamatory drugs, genetic predisposition and bladder cancer risk in Spain. • Cancer Epidemiol Biomarkers & Prev 2006;15(9):1696-702. • IF: 4.460 48. Molina-Garrido MJ, Mora Rufere A, Rodríguez Lescure A, Cascón Pérez JD, Ardoy F, Guillén Ponce C, Carrato Mena A. • Recurrent pericardial effusion as the initial manifestation of primary diffuse pericardial malignant mesothelioma. • Clin Transl Oncol 2006;8(9):694-6. 49. Kogevinas M, Fernandez F, Garcia-Closas M, Tardon A, Garcia-Closas R, Serra C, Carrato A, Castano-Vinyals G, Yeager M, Chanock SJ, Lloreta J, Rothman N, Real FX, Dosemeci M, Malats N, Silverman D. • Hair dye use is not associated with risk for bladder cancer: Evidence from a case-control study in Spain. • Eur J Cancer 2006;42(10):1448-54. • IF: 3.706 50. Carrato A, Gallego Plazas J, Guillén-Ponce C. • VEGF theraphy, a new approach to colorrectal cancer therapy. • Expert Rev Anticancer Ther 2006;6(10):1385-1396. 51. Maciá Escalante S, Rodríguez Lescure A, Pons Sanz V, Martínez Banaclocha N, Guillén Ponce C, Carrato Mena A. Memoria 2005 · 2006 321
Page 1:
12. Docencia, formación, investiga
Page 4 and 5:
MEMORIA DOCENTE ATENCIÓN PRIMARIA
Page 6 and 7:
Page 8 and 9:
Page 10 and 11:
Page 12 and 13:
Page 14 and 15:
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
ATENCIÓN ESPECIALIZADA. DOCENCIA S
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105: ATENCIÓN ESPECIALIZADA. DOCENCIA S
Page 200 and 201: COMITÉ ÉTICO DE ENSAYOS CLÍNICOS
Page 202 and 203: COMITÉ ÉTICO DE ENSAYOS CLÍNICOS
Page 204 and 205:
FUNDACIÓN INVESTIGACIÓN BIOMÉDIC
Page 206 and 207:
FUNDACIÓN INVESTIGACIÓN BIOMÉDIC
Page 208 and 209:
374 Hospital General de Elche
Page 210:
UNIDAD DE ASESORAMIENTO EN METODOS
show all

Docencia, formación, investigación y 12. calidad - Hospital General ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?